Jonathan Smith

DNA manufacturing was a hot topic in biotech investments in October, with immuno-oncology and insect protein also drawing big investor excitement.  After the huge biotech investment rounds that took place in September, October was a quieter month for private European and Israeli life sciences firms. Collectively, they raised €555.6M in 37 deals. This was less […]

Initial public offerings by European biotech companies were hot in September, and companies developing technologies including sequencing and bioinformatics received big private and public investments.  Last month, European and Israeli biotech companies raised over €1.5B in 42 deals, which included initial public offerings (IPOs) and private financing rounds. This was more than triple the total […]

UK and German companies led the European biotech funding race in August, specializing in cell therapy, diagnostics, and RNA-based treatments. With summer in full swing, August was a quieter month than July in terms of European biotech funding. Private biotechs in Europe and Israel — in addition to those going public in an initial public […]

Nordic biotechs yielded some of Europe’s biggest biotech funding rounds in July, as did developers of cultured meat and other protein alternatives. July saw a continuing buzz of biotech fundraising activity in Europe. In the venture capital arena, the investors Sofinnova and Panakès Partners closed new funds to target life sciences companies, including those in […]